Could Hepatitis B Vaccine Act as An Adjuvant to Lower Risk and Relapses of Cancer?

This article is protected by copyright. All rights reserved. PMID: 31002181 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31002181?dopt=Abstract

Source: Clinical Genitourinary Cancer - April 18, 2019 Category: Cancer & Oncology Authors: Altinoz MA, Ozpinar A, Ozpinar A, Hacker E, Elmaci İ Tags: Clin Exp Pharmacol Physiol Source Type: research

More News: Acute Leukemia | Bile Duct Cancer | Bladder Cancer | Brain | Breast Cancer | Cancer | Cancer & Oncology | Cancer Vaccines | Cholangiocarcinoma | Colon Cancer | Colorectal Cancer | Epidemiology | Hepatitis | Hepatitis B | Hepatitis Vaccine | Leukemia | Liver | Melanoma | Neuroblastoma | Neurology | Skin Cancer | Study | Urology & Nephrology | Vaccines | Veterinary Vaccinations